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Malaria elimination is back on the agenda, but it remains challenging for countries to make the transition from
effective control to elimination. Many other infectious diseases have been targeted by globally-coordinated
elimination advocacy campaigns, and advocacy has been considered an essential component of the success of
other disease elimination programmes. What can the malaria community learn from these successes? A review of
infectious disease elimination programmes to identify successful elements of advocacy for disease elimination was
undertaken. Key elements are: (i) a global elimination plan, supported by international health bodies; (ii) thorough
costings and tools to support the business case; (iii) an approach that is positioned within a development framework;
(iv) core elimination advocacy messages; (v) provision of advocacy tools for partners (vi) extensive and effective
community engagement; and (vii) strong partnerships. These features provide insights into ‘what works’ in global
elimination advocacy. Advocacy is a powerful tool to support the long-term political and financial commitment
necessary for malaria elimination. The global malaria community needs to work together, to ensure that the early steps
towards the end goal of malaria elimination are taken.
Keywords: Malaria, Malaria elimination, Disease eradication, Health communication, Public-private sector partnerships,
Advocacy, Community engagement, Global health planning international developmentBackground
The World Health Organization (WHO) defines malaria
elimination as “ reduction to zero of the incidence of
infection caused by a specified malaria parasite in a defined
geographical area as a result of deliberate efforts” [1]. This
requires ongoing and deliberate efforts to prevent reintro-
duction of transmission. Eradication is “the permanent
reduction to zero of the worldwide incidence of infec-
tion caused by human malaria parasites as a result of
deliberate efforts” [2]. Current approaches to malaria
elimination have been influenced by the earlier Global
Malaria Eradication Programme (GMEP), which ran
from 1955 to 1969. Although the geographical distribution
of malaria was reduced during this programme, technical
challenges and the resurgence of malaria in many* Correspondence: m.whittaker@uq.edu.au
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many decades [3].
Since 2000, there has been an increasing political drive
to eliminate malaria [2]. Reducing the burden of malaria
is a central component of the Millennium Development
Goals (MDGs) [2]. New tools have become widely avail-
able, such as artemisinin-based combination therapy,
insecticide-treated bed nets, and rapid diagnostic tests
[2]. The Roll Back Malaria partnership has listed elimin-
ation as a long-term goal, and donors such as the Bill
and Melinda Gates Foundation have made strong calls for
malaria elimination.
Donor funding for malaria control has increased sub-
stantially during this period, and there has been a signifi-
cant increase in the proportion of the world’s population
living in malaria free areas [4,5]. Since 2007, three coun-
tries have been certified as malaria-free, seven countries
are currently preventing re-introduction to prepare for
certification, and ten countries are currently in the elimin-
ation phase [2]. Lessons from the GMEP have highlightedral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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grammes and partners, and implementing elimination
programmes flexibly, with capacity to adapt to changing
circumstances [3].
Most malaria-endemic countries have not yet reached
WHO criteria for pre-elimination, although some of these
may have elimination as a long-term goal [6]. Effective and
sustained control is an important prerequisite for elimin-
ation. However, the transition from sustained control, once
achieved, to elimination demands a shift in focus. It re-
quires significant national commitment, and sustained
investment and financial support. Advocacy can acceler-
ate the transition to, and support the sustaining of, mal-
aria elimination via several means. Through coordinated
campaigns, advocacy can sustain commitment from both
donor and endemic countries, strengthen national owner-
ship and partnerships, and position elimination as a driver
of development goals.
Elimination advocacy will be informed by the experi-
ences and best practices identified in countries that have
successfully achieved elimination. However, this is not the
only source of experience. Many other infectious diseases
have been targeted by globally-coordinated elimination
campaigns. Advocacy has been vital for achieving political
prioritization of some neglected tropical diseases (NTD)
and subsequent successes [7]. The ongoing success of polio
eradication in India has been partly attributed to effect-
ive advocacy [8,9]. These programmes exhibit a number
of common features, providing insights into ‘what works’
in global elimination advocacy.
Review methodology
A selective review of infectious disease elimination pro-
grammes to identify successful elements of advocacy for
disease elimination was undertaken. This process was
inclusive, where programmes were included for review
if they had documented positive health impact within a
particular region, or if a particular element of programme
implementation was reported as successful within the
literature. Searches were conducted on peer-reviewed
databases (e.g., Medline, Web of Science), elimination
programme websites, lead organization websites (e.g.,
World Health Organization, WHO) and internet search
engines (e.g., Google). Articles and reports were initially
reviewed by one author, and potential themes related to
effective advocacy were identified. These themes were
then reviewed and grouped in discussion with all authors.
Positive and negative experiences, successes, and challenges
were included if they were applicable to advocacy for
malaria elimination. These were then framed as a ’rec-
ommendation’. Lessons that were applicable only to a
single disease or not related to advocacy (e.g., technical
challenges related to an emerging drug side effect) were
not considered in the current review.Developing a global elimination plan
Background
Global elimination plans are a powerful tool to move the
elimination agenda forward, and support advocacy for
implementation of elimination strategies at global and
national levels.
Experience from other diseases
For example, the global push to eliminate lymphatic fil-
ariasis (LF) began in response to a 1997 World Health
Assembly (WHA) resolution to eliminate LF by 2020 [10].
Subsequent development of the Global Programme for the
Elimination of Lymphatic Filariasis (GPELF) created a mo-
mentum that resulted in 34 countries establishing elimin-
ation programmes [10].
Similarly, recent reductions in the global burden of
leprosy began in response to a 1991 WHA Resolution to
“eliminate leprosy as a public health problem” by the end
of the millennium, defined as reaching a prevalence of less
than 1 leprosy case per 10,000 population [11,12]. Leprosy
elimination provides an example of how global planning
can have unexpected influences on national programmes.
By 2001, the global prevalence of leprosy reached less than
1 case per 10,000. However, because of regional cluster-
ing of leprosy prevalence, leprosy remained above this
threshold in 14 countries. Leprosy support groups have
expressed concern that declaring leprosy elimination at
a global level led to the perception that leprosy was no lon-
ger a concern, and made it difficult for groups to advocate
national leprosy programming in endemic countries [13].
A series of follow-up plans attempted to redress this issue,
including the WHO ‘Global Strategy for Further Reducing
the Leprosy Burden and Sustaining Leprosy Control Activ-
ities: 2006-2010’, and a bi-regional strategy to ‘Sustain
Leprosy Services in Asia and the Pacific’. Major reduc-
tions in prevalence of leprosy occurred during these pe-
riods [13]. Global and regional strategies leveraged national
commitment from endemic countries to extend their cover-
age of leprosy services, and provided a foundation for part-
nerships between WHO and donors that enabled WHO to
provide free multidrug treatment for leprosy [11,14]. At
country level, global plans provided an impetus for India to
commit to elimination targets. This led to funding partner-
ships, national campaigns [15], and continued reductions in
prevalence [13].
There are multiple elements in the process of obtain-
ing a global consensus on the need to target elimination
and developing a strategy for action, from WHA decla-
rations and WHO strategies, through to global plans.
Most elimination programmes incorporate several of these
processes, making it difficult to disentangle their relative
importance. However, effective disease elimination pro-
grammes typically involve elimination plans, which have a
number of common elements:
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define ‘elimination’ and identify a specific target, and
time frame for achieving this target;
 Defined strategy: effective plans provide a defined,
evidence-based, technical strategy for working
towards elimination, with backing from key
stakeholders such as those in the areas of technical
support and programme management [16]. For
example, GPELF provides an elimination strategy
focusing on mass drug administration with defined
targets and timeframes [17]. Many plans are
accompanied by operational guidelines in areas such
as integrated health services, surveillance, or
treatment [11,18];
 Widely endorsed: ideally, elimination plans should be
endorsed by international bodies such as the World
Health Assembly and key regional and national
bodies [19];
 Avoid a ‘one size fits all’ approach: effective plans
can target local needs and be adjusted to
incorporate changes in technology, or emerging
challenges. A factor attributed to the success of
polio elimination in India is tailoring of the Global
Polio Eradication Initiative (GPEI) to the local
context, and combining this with innovative social
mobilization approaches [20];
 Incorporates an endgame plan: endgame
management is a key challenge for elimination
programmes, especially maintaining political and
financial support as the burden of disease diminishes
[4,21,22]. The Polio Eradication & Endgame
Strategic Plan 2013–2018 [20] ensures that this
period is coordinated globally, and investments and
elimination can be sustained in the longer term [23];
 Promotes international and regional collaboration:
implementing elimination plans in border areas
between endemic countries [4,24] require
collaboration between countries, balancing national
strategies with regional, or globally coordinated
plans [25].
Applying lessons to malaria
The current global approach for malaria control and
elimination is provided in the Global Malaria Action Plan
(GMAP). This was developed in 2008, supported by the
Roll Back Malaria (RBM) Partnership. The current GMAP
objectives are to: (i) reduce global malaria deaths to near
zero by end 2015; (ii) reduce global malaria cases by 75%
by end 2015; and (iii) eliminate malaria by end 2013 in at
least eight to ten new countries (since 2008), including the
entire WHO European Region. Although elimination is a
component of this plan, the overall emphasis remains on
effective control. However, as countries sustain control
and become ready to consider elimination, few resourcesare available to facilitate this transition [26]. A global elim-
ination plan provides a platform for the associated advo-
cacy materials and an impetus for countries to develop
national elimination plans. It also assists country and re-
gional partners to leverage necessary political and financial
support. Planned revisions to the GMAP are currently be-
ing undertaken (GMAP 2) [27]. This provides an oppor-
tunity for these lessons and new approaches to elimination
to be incorporated into the new GMAP.
Provide tools to support the business case
Background
Elimination programmes require long-term financial
investment.
Experience from other diseases
For NTD elimination, strong cases for return on investment
corresponded with improved funding and programme suc-
cess. For example, a series of cost-benefit analyses have led
to the GPELF being described as a ‘best buy’ in global
health, and supported continuing programme implemen-
tation [28]. The demonstrated cost-effectiveness of the
programme is hailed as a major reason for its success [12].
The Global Polio Eradication Initiative developed an eco-
nomic case for eradication, comparing cost effectiveness
of eradication with two alternatives to eradication [29,30].
The Polio Eradication and Endgame Strategic Plan 2013–
2018 incorporated detailed costings for all activities [31].
It was estimated that full implementation of the plan
would require a budget of US $5.5 billion, covering
vaccination, monitoring and surveillance costs, and in-
frastructure that will benefit other health programmes.
To ensure potential donors have confidence in elimination
plans, GPEI regularly invites donors to provide ongoing
input [32].
Applying lessons to malaria
Much of the economic analyses available to inform in-
vestment in malaria programmes has focused on malaria
control rather than elimination [33,34]. Costs to achieve
elimination may be higher than control, and as the burden
of disease diminishes, the cost per life saved, a common
metric used for prioritization, becomes greater [35]. As
prevalence decreases, more sensitive methods of case de-
tection and surveillance are required which can lead to
rising costs [1,21]. The importance of stable financing is
highlights by a recent systematic review of 75 malaria re-
surgence events across 61 countries. This review reported
that disruptions in financial support was most common
reason for malaria resurgence [22]. Thus, access to clearly-
defined cost analyses for both elimination and alternative
actions such as maintaining control, is vital for policy-
makers considering elimination planning. This information
is also important for donors, who increasingly need to
Whittaker et al. Malaria Journal 2014, 13:221 Page 4 of 8
http://www.malariajournal.com/content/13/1/221focus on results and return on investment, and for those
advocating for investment in elimination [34,35]. Although
this may be politically challenging, quantifying health and
economic benefits, direct and indirect, can facilitate
commitment to long-term investment [16]. The Malaria
Elimination Group has provided initial case studies for
elimination costs [36], but full costings and cost-benefit
analyses are not yet available for malaria elimination
[34,35].
To advocate for malaria elimination, the malaria com-
munity need clearly quantified costs and budgets for elim-
ination programmes, and cost-benefit analyses. These
analyses will inform approaches to programme financing
and partnerships with donors and policy makers. They
will also assist in managing stakeholder expectations
and identifying gaps in support [25,35]. The changing
culture of development financing means there will be
greater emphasis on concepts such as value for money,
cost effectiveness, performance-based funding and return
on investment [6]. As countries move towards elimination,
enhanced regional activities will become more important.
Given that the Global Fund allocates only a small amount
of its funding to regional proposals, it is likely that advo-
cacy efforts will also need to target financing mechanisms
and the structure of funding available [4].
Position elimination within a development framework
Background
There have been significant changes in the landscape for
funding and implementing global health programmes: fun-
draising and resource mobilization for malaria program-
ming no longer occur in isolation from global health and
development financing [10,34,37]. ‘Competing’ with other
health programmes for funding creates inefficiencies and
siloing of resources and expertise. In the current resource-
constrained environment, this means that advocates for
malaria elimination need to work within a developmental
framework [31], positioning malaria elimination as a key
driver promoting the achievement of other MDGs [7], such
as those relating to maternal and child health (MDG4
and 5). In the longer term, elimination advocacy also
needs to be positioned for a post-MDG environment,
focusing on equity, universal health coverage and sus-
tainability, and also with greater emphasis on economic
return on investment.
Experience from other diseases
For example, GPELF is promoted as an opportunity to
reduce poverty and support sustainable development [37].
The campaign integrates LF elimination with other disease
programmes and MDGs, strengthening of health services
and universal health coverage, promoting human resource
development (including gendered development), availabil-
ity of technological advances, support for governance andleadership, international networking, and stimulation of
international investment [10,25,28,37]. For example, in
the Philippines, LF elimination programmes are seen to
provide synergies with programmes that work towards
poverty reduction, via improving health care systems and
access for poor communities [37]. This approach can
reduce competition between health and development
programming. It can also ensure ongoing national and
community support for elimination programmes, even
during periods of low disease burden. In the early stages of
polio elimination programmes in India and Pakistan, dis-
parity between well-funded polio services and other health
services which were poorly funded contributed to commu-
nity mistrust in elimination programmes, which hampered
programme success [38]. Since this period, polio elimin-
ation plans have ensured that elimination programming
augments existing health services. The Polio Eradication &
Endgame Strategic Plan 2013–2018 [32] specifically bud-
gets for health systems strengthening, ensuring that core
elements of elimination activities also support the delivery
of diverse health services to children.
Applying lessons to malaria
There are many opportunities to integrate malaria elimin-
ation advocacy within a development framework and cre-
ate synergies with the development community. Malaria
impacts heavily on MDG 4 (reduce child mortality) and 5
(improve maternal health), and addressing malaria has
demonstrated benefits on all causes of child mortality [6].
In addition, reducing the malaria burden can lead to im-
provements in health care systems [37], poverty [39], and
economic development [16]. Well-funded malaria inter-
ventions can also be used as a vehicle for strengthening
maternal and child health care systems and conversely,
the recent growth in child and maternal health funding
also provides opportunities to implement integrated mal-
aria elimination interventions within this setting [6,40,41].
Such integration can extend service coverage, address
gaps in service delivery, and share costs [40]. Malaria
elimination also has the potential to align with other areas
of development, such as housing improvements [42], water,
sanitation and hygiene (WASH) programmes and climate
change adaptation. Placing malaria elimination within the
framework of the global development agenda can generate
valuable synergies for both funding and programming, and
creates the opportunity to ensure that malaria elimination
contributes to real improvement in diverse health and
social outcomes for communities.
Develop targeted messages
Background
Communication is an important component of advocacy,
sustaining necessary financial, political and community
support. The landscape for malaria elimination is changing:
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models need to operate in development-oriented frame-
works, and global planning involves cooperation between
diverse partners. Within this landscape, it becomes increas-
ingly important for advocates to identify the core messages,
and communicate these effectively to target audiences.
Experience from other diseases
Successful elimination programmes have developed effect-
ive messaging, generating programme support. ‘Make an
Invisible Killer Visible’ supported the agenda for maternal
and neonatal tetanus (MNT) elimination. ‘Finish the Fight’
reminded donors and supporters of the importance of
the endgame in polio elimination. ‘Give a Human Face
to Leprosy’ reminds audiences about the ongoing burden
of leprosy in affected countries.
Applying lessons to malaria
Advocates of malaria elimination need to develop key elim-
ination messages. RBM provides an example of advocacy
messaging ‘Sustain Gains, Save Lives: Invest in Malaria’ [6].
Such messages could be adapted for elimination advocacy,
for example ‘Sustain Gains Made, Protect Lives, Invest in
Malaria Elimination’. Effective messages need to be: clear
compelling and concise; consistent and convincing; simple
and direct; and frequently reinforced by a variety of sources
[43]. Powerful language can create a sense of urgency, but
should not resort to sensationalism or overpromise, as
these may diminish the impact of the message and the
programme [19]. Impact can be enhanced by combining
messages with a human face and a visually interesting cam-
paign [9]. These messages may be developed to target
major donors, inspire potential partners or generate polit-
ical support at various levels.
Provide communication tools
Background
Communications tools can empower those advocating at
international, national and local levels.
Experience from other diseases
Many effective elimination campaigns have provided nu-
merous tools to partners, enabling them to participate in
targeted advocacy efforts: for example, the GPELF was
supported by the LF Support Center, which provided a
Fundraising and Advocacy Toolkit for its partners. This
contains a comprehensive range of advocacy materials,
such as ‘Top 10 Communication Messages’, a ‘Checklist
for Preparing an Effective News Release’, and ‘10 Tips for
Writing Letters to Government Officials’.
Applying lessons to malaria
It is difficult to estimate the effectiveness of such tools,
and few studies detail their specific uptake and impact.However, provision of templates and key messages can
ensure that elimination campaigns utilize consistent messa-
ging. In addition, tools can increase the number of partners
participating in advocacy activities, via building capacity or
confidence to engage in advocacy. RBM does provide a
series of advocacy tools [6,44,45]. However, these are not
elimination focused. Although some malaria elimination
tools are emerging, these are not advocacy focused; for
example, The Elimination Scenario Planning toolkit pro-
vides tools to support countries in sub-Saharan Africa
which are considering progress towards elimination [46].
Engage with communities
Background
Communities affected by malaria must be supported as
active participants in elimination, identifying priorities
and influencing local programming approaches. It is well
recognized that community involvement and ownership
can be important drivers of programme success [23,47,48].
High community involvement was identified as an essential
factor enabling malaria to be elimination from the island of
Aneityum, Vanuatu [23]. Conversely, loss of community
support may lead to donors withdrawing funds and poten-
tial collapse of a programme [3,21].
Experience from other diseases
During the early 2000s, there were a number of setbacks
to polio elimination in India and Pakistan. Children in poor
Muslim areas with poor sanitation were more likely to be
missed in immunization activities due to poor understand-
ing about the need for repeated vaccinations and emerging
suspicions about programme safety [38,49]. Widespread
media campaigns and intense social mobilization were
initiated in response. Health workers and communica-
tors worked with community and village health author-
ities, conducted repeated family visits in high-risk areas
and advocated with community leaders. Evaluations dem-
onstrate that these activities led to improved attendance at
vaccination booths, reduced vaccine refusal rates, and a
reduction in wild polio cases [38].
Success of the onchocerciasis elimination programmes
in Nigeria is linked to community-ownership [50]. Early
drug distribution services faced a number of challenges:
mobile health workers (a significant cost burden on the
programme) were reluctant to travel to high-risk areas,
the timing of community visits was often inconvenient for
communities, and treatment benefits were not always well
communicated. To address these problems, community-
based drug distribution was implemented. Following some
success, a community-directed strategy was then adopted,
where communities received training and made decisions
about drug distribution methods. This transformed the
programme, with an increase in the number of treatments
distributed, and the number of staff trained. Services
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nity needs [50].
Applying lessons to malaria
The experience from the polio elimination programme
highlights how advocates for elimination can benefit from
working with specialists in community engagement, social
mobilization and communications. Experience from spe-
cialists in this area indicates that time required for effect-
ive community engagement is often underestimated - it is
important that these processes are given adequate time
and budgeting in the design phase. Strategies for engaging
communities should be flexible, and adaptable to suit
diverse cultural, sociopolitical, geographical and health
characteristics of communities. The experience from
onchocerciasis elimination programmes highlights the
importance of making time available to engage with
geographically remote communities, or those with a his-
tory of conflict. Although community involvement is
promoted by WHO and RBM, Kaneko suggests that
“community involvement in malaria elimination … is
poorly documented” [23]. Community engagement for
malaria elimination can be more challenging than for
control. As the burden of disease diminishes, communi-
ties may shift their focus to other health problems, eg,
dengue in Southeast Asia. Not only do advocates need
to raise awareness and create demand and sustained sup-
port for elimination activities, engagement also provides a
key opportunity to identify community needs, and ensure
that advocacy and programming activities are integrated
with these needs [23,51].
Create strong partnerships
Background
Strong partnerships are a key feature of effective elimin-
ation programmes [52], and ineffective partnerships have
been cited as a limitation of the GMEP [3].
Experience from other diseases
Partnerships typical of effective elimination programmes
involve broad engagement, comprising major international
bodies such as WHO or UNICEF, national ministries of
health, major donors, research and technical experts, and
NGOs [53]. The partnership to support MNT elimination
involves UNICEF, the US Committee for UNICEF, the Bill
and Melinda Gates Foundation, Becton Dickinson (BD),
WHO, PATH (Programme for Appropriate Technology in
Health), United Nations Population Fund, as well major
donors. The partnership between UNICEF and P&G
Pampers began in 2006, with the UK-based campaign “1
pack = 1 vaccine”. This has expanded to 60 countries, with
all partners supporting elimination [54]. Private sector
partnerships have generated important benefits for elimin-
ation programmes. For example, GPELF partners withtwo pharmaceutical donors (Merck & Co Inc, and
GlaxoSmithKline), which provide significant donations
of medications ‘for as long as needed’ to LF-endemic
countries [10,28,31].
Another success factor is clear leadership and central co-
ordination via a lead agency. UNICEF has a clear mandate
to lead the global partnership for MNT elimination [54].
The Global Guinea Worm Eradication Programme pro-
vides an additional example of the importance of partner-
ships. The early years of this programme lacked clear
partner coordination [55,56], and were associated with
limited funding and failure to meet programme targets
[55,56]. In the last decade, strong coordination between
the Carter Center and WHO led to joint advocacy to
major donors, resulting in major funding pledges [55,56].
Lead agency facilitation is especially important when there
is a large number of partner organizations, with diverse
organizational priorities, theoretical frameworks and oper-
ating approaches.
Applying lessons to malaria
The shift from malaria control to elimination and efforts
in border regions will require a balance between partici-
pating countries setting their own priorities, and regional
and multi-country strategies and funding mechanisms
[4]. Regional leadership will become increasingly import-
ant. The RBM Partnership is a broad-based coalition of
more than 500 public and private sector partners, which
facilitates and coordinates malaria control activities [2,5].
The RBM approach allows countries to set their own
priorities, whilst supporting sector-wide approaches. The
Asia-Pacific Malaria Elimination Network (APMEN) is
an example of a country-led regional collaboration that
aims to support countries adopting malaria elimination
as a national or sub-national goal. APMEN works closely
with RBM, global agencies, such as WHO, and many
regional partners in academic, development, NGO and
private sectors [4]. The new strategic plan for RBM may
provide an opportunity for them to gain a mandate to
broaden its scope to focus on elimination.
Conclusion
There have been massive gains in malaria control and
there is increasing recognition of the importance of mal-
aria elimination as a long-term goal. Once effective con-
trol is sustained, many countries are ready to consider
elimination. However, it remains difficult to facilitate the
transition to elimination without the long-term political
and financial support that elimination requires.
Advocacy is an important tool that the global malaria
community should use to support the transition to elim-
ination, and sustain gains made in malaria control. Ad-
vocacy can leverage political commitment, create new
funding opportunities and support partnerships. These
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for the malaria community. The major challenges relate to
obtaining a global consensus to endorse a defined strategy
focusing on elimination, and developing tools to support
the business case. Economic modelling is required to de-
velop robust cost-benefit modelling that focuses on elimin-
ation targets. This is a core need for ongoing elimination
advocacy. Some of these lessons involve extending existing
efforts. For example, the malaria community has a history
of developing messages and communications tools; the
current opportunity is to extend this work to incorporate
elimination targets. Similarly, there are a number of global
and regional malaria partnerships that could provide a plat-
form for elimination advocacy - these partnerships need to
be provided with the mandate to focus on elimination, with
a clear structure of coordination. Most importantly, these
lessons also highlight opportunities for the malaria com-
munity to embrace new approaches. Advocates for malaria
elimination can work within developmental frameworks -
building synergies with other health and social pro-
gramming - to maximize outcomes from investment and
prevent competition for increasingly scarce resources.
Engaging effectively with communities is vital for build-
ing support and optimizing local implementation that is
essential for effective long-term programming.
Malaria elimination is a dynamic processes [25]. Elim-
ination advocacy will need to adapt to new technologies
and research findings, emerging successes and challenges,
changes in the socio-political landscape of eliminating
countries, and changes in global health financing. The
global malaria community needs to work together, ensur-
ing the early steps towards the end goal of malaria elimin-
ation are taken.
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